P. Laramee, J. Kusel, S. Leonard, H. Aubin, C. François et al., The Economic Burden of Alcohol Dependence in Europe, Alcohol and Alcoholism, vol.48, issue.3, pp.259-69, 2013.
DOI : 10.1093/alcalc/agt004

A. European-medicines, Guideline on the development of medicinal products for the treatment of alcohol dependence, 2010.

G. Marlatt and K. Witkiewitz, Harm reduction approaches to alcohol use, Addictive Behaviors, vol.27, issue.6, pp.867-86, 2002.
DOI : 10.1016/S0306-4603(02)00294-0

R. Kohn, S. Saxena, I. Levav, and B. Saraceno, The treatment gap in mental health care, Bull World Health Organ, vol.82, issue.11, pp.858-66, 2004.

H. Aubin and J. Daeppen, Emerging pharmacotherapies for alcohol dependence: A systematic review focusing on reduction in consumption, Drug and Alcohol Dependence, vol.133, issue.1, pp.15-29, 2013.
DOI : 10.1016/j.drugalcdep.2013.04.025

H. Autorité and D. Santé, Société Française d'Alcoologie Conférence de consensus 7 et 8 mars 2001: modalités de l'accompagnement du sujet alcoolodépendant après un sevrage

H. Autorité and D. Santé, Société Française d'Alcoologie Conférence de consensus du 17 mars 1999: Objectifs, indications et modalités du sevrage du patient alcoolodépendant

B. Rolland, V. Laprevote, P. Geoffroy, D. Guardia, R. Schwan et al., Abstinence dans l???alcoolod??pendance??: approche critique et actualis??e des recommandations nationales de 2001, La Presse M??dicale, vol.42, issue.1, pp.19-25, 2001.
DOI : 10.1016/j.lpm.2012.02.038

O. Cottencin, J. Harbonnier, D. Guardia, R. B. Danel, and T. , The System of Medical Treatment for Addiction in France, International Journal of Mental Health, vol.6, issue.3, pp.19-26, 2014.
DOI : 10.1192/bjp.bp.108.054742

B. Rolland, R. Bordet, and O. Cottencin, ALCOHOL-DEPENDENCE: THE CURRENT FRENCH CRAZE FOR BACLOFEN, Addiction, vol.65, issue.4, pp.848-857, 2012.
DOI : 10.1111/j.1360-0443.2011.03752.x

S. Française-d-'alcoologie, Alcohol misuse: screening, diagnosis and treatment, 2015.

S. Française-d-'alcoologie, Mésusage de l'alcool: dépistage, diagnostic et traitement Recommandations de bonne pratique, Alcoologie et Addictologie, vol.37, issue.1, 2015.

B. Rolland, K. Mann, F. Paille, and H. Aubin, The New French Guidelines on Alcohol Misuse: An Initiative for Strengthening Cross-European Interplay, Addiction, vol.20, issue.8, pp.1362-1365, 2015.
DOI : 10.1111/add.12997

H. Autorité and D. Santé, Practice Guidelines Clinical practice guidelines " method, 2011.

H. Autorité and D. Santé, About HAS

D. Gastfriend, J. Garbutt, H. Pettinati, and R. Forman, Reduction in heavy drinking as a treatment outcome in alcohol dependence, Journal of Substance Abuse Treatment, vol.33, issue.1, pp.71-80, 2007.
DOI : 10.1016/j.jsat.2006.09.008

A. Luquiens and H. Aubin, Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene, Patient Prefer Adherence, vol.8, pp.1347-52, 2014.

G. Vaillant, A 60-year follow-up of alcoholic men, Addiction, vol.6, issue.8, pp.1043-51, 2003.
DOI : 10.1046/j.1360-0443.2003.00422.x

A. Gual, F. Bravo, A. Lligoña, and J. Colom, Treatment for Alcohol Dependence in Catalonia: Health Outcomes and Stability of Drinking Patterns over 20 Years in 850 Patients, Alcohol and Alcoholism, vol.44, issue.4, pp.409-424, 2009.
DOI : 10.1093/alcalc/agp032

M. Subbaraman and J. Witbrodt, Differences between abstinent and non-abstinent individuals in recovery from alcohol use disorders, Addictive Behaviors, vol.39, issue.12, pp.1730-1735, 2014.
DOI : 10.1016/j.addbeh.2014.07.010

Z. Al-otaiba, B. Worden, B. Mccrady, and E. Epstein, Accounting for self-selected drinking goals in the assessment of treatment outcome., Psychology of Addictive Behaviors, vol.22, issue.3, pp.439-482, 2008.
DOI : 10.1037/0893-164X.22.3.439

S. Adamson, N. Heather, V. Morton, and D. Raistrick, Initial Preference for Drinking Goal in the Treatment of Alcohol Problems: II. Treatment Outcomes, Alcohol and Alcoholism, vol.45, issue.2, pp.136-178, 2010.
DOI : 10.1093/alcalc/agq005

W. Hall and D. Zador, The alcohol withdrawal syndrome, The Lancet, vol.349, issue.9069, pp.1897-900, 1997.
DOI : 10.1016/S0140-6736(97)04572-8

J. Maldonado, Y. Sher, J. Ashouri, K. Hills-evans, H. Swendsen et al., The ???Prediction of Alcohol Withdrawal Severity Scale??? (PAWSS): Systematic literature review and pilot study of a new scale for the prediction of complicated alcohol withdrawal syndrome, Alcohol, vol.48, issue.4, pp.375-90, 2014.
DOI : 10.1016/j.alcohol.2014.01.004

M. Schuckit, Alcohol-use disorders, The Lancet, vol.373, issue.9662, pp.492-501, 2009.
DOI : 10.1016/S0140-6736(09)60009-X

M. Hayashida, A. Alterman, A. Mclellan, O. Brien, C. Purtill et al., Comparative Effectiveness and Costs of Inpatient and Outpatient Detoxification of Patients with Mild-to-Moderate Alcohol Withdrawal Syndrome, New England Journal of Medicine, vol.320, issue.6, pp.358-65, 1989.
DOI : 10.1056/NEJM198902093200605

L. Amato, S. Minozzi, S. Vecchi, and M. Davoli, Benzodiazepines for alcohol withdrawal, Cochrane Database Syst Rev, vol.152, issue.3, p.5063, 2010.
DOI : 10.1002/14651858.CD005063.pub3

J. Rehm, A. Allamani, and H. Aubin, People with Alcohol Use Disorders in Specialized Care in Eight Different European Countries, Alcohol and Alcoholism, vol.50, issue.3, pp.310-318, 2015.
DOI : 10.1093/alcalc/agv009

J. Daeppen, P. Gache, and U. Landry, Symptom-Triggered vs Fixed-Schedule Doses of Benzodiazepine for Alcohol Withdrawal, Archives of Internal Medicine, vol.162, issue.10, pp.1117-1138, 2002.
DOI : 10.1001/archinte.162.10.1117

J. Sullivan, K. Sykora, J. Schneiderman, C. Naranjo, and E. Sellers, Assessment of Alcohol Withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar), Addiction, vol.26, issue.11, pp.1353-1360, 1989.
DOI : 10.1111/j.1360-0443.1989.tb00737.x

P. Cushman, R. Forbes, W. Lerner, and M. Stewart, Alcohol Withdrawal Syndromes: Clinical Management with Lofexidine, Alcoholism: Clinical and Experimental Research, vol.282, issue.2, pp.103-111, 1985.
DOI : 10.1001/jama.239.14.1409

J. Sonne, P. Andreasen, S. Loft, M. Døssing, and F. Andreasen, Glucuronidation of oxazepam is not spared in patients with hepatic encephalopathy, Hepatology, vol.29, issue.6, pp.951-957, 1990.
DOI : 10.1002/hep.1840110607

N. Latt and G. Dore, Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders):911?5. 35. US Department of Helath & Human Services, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism. Helping patients who drink too much. A clinican's guide, Intern Med J, vol.4415, issue.9, p.9, 2005.

N. Furtwaengler and R. De-visser, Lack of international consensus in low-risk drinking guidelines, Drug and Alcohol Review, vol.28, issue.1, pp.11-19, 2013.
DOI : 10.1111/j.1465-3362.2012.00475.x

C. Bouza, A. M. Magro, A. Muñoz, A. Amate, and J. , Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review, Addiction, vol.99, issue.7, pp.811-839, 2004.

N. Maisel, J. Blodgett, P. Wilbourne, K. Humphreys, and J. Finney, Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?, Addiction, vol.154, issue.12, pp.275-93, 2013.
DOI : 10.1111/j.1360-0443.2012.04054.x

D. Jonas, H. Amick, and C. Feltner, Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings, JAMA, vol.311, issue.18, pp.1889-900, 2014.
DOI : 10.1001/jama.2014.3628

C. Jørgensen, B. Pedersen, and H. Tønnesen, The Efficacy of Disulfiram for the Treatment of Alcohol Use Disorder, Alcoholism: Clinical and Experimental Research, vol.64, issue.2, pp.1749-58, 2011.
DOI : 10.1111/j.1530-0277.2011.01523.x

M. Skinner, P. Lahmek, H. Pham, and H. Aubin, Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis, PLoS ONE, vol.74, issue.2, p.87366, 2014.
DOI : 10.1371/journal.pone.0087366.s002

J. Chick, Safety Issues Concerning the Use of Disulfiram in Treating Alcohol Dependence, Drug Safety, vol.20, issue.5, pp.427-462, 1999.
DOI : 10.2165/00002018-199920050-00003

J. Dupouy, J. Fournier, and E. Jouanjus, Baclofen for alcohol dependence in France: Incidence of treated patients and prescription patterns???A cohort study, European Neuropsychopharmacology, vol.24, issue.2, pp.192-201, 2014.
DOI : 10.1016/j.euroneuro.2013.09.008

B. Rolland, F. Paille, B. Fleury, O. Cottencin, A. Benyamina et al., Off-Label Baclofen Prescribing Practices among French Alcohol Specialists: Results of a National Online Survey, PLoS ONE, vol.7, issue.302, p.98062, 2014.
DOI : 10.1371/journal.pone.0098062.t003

C. Müller, O. Geisel, and P. Pelz, High-dose baclofen for the treatment of alcohol dependence (BACLAD study): A randomized, placebo-controlled trial Baclofen for the Treatment of Alcohol Drinkers -Full Text View -ClinicalTrials.gov, Eur Neuropsychopharmacol BACLOVILLE study, vol.2515, issue.46, pp.1167-77, 2012.

A. Study, Efficacy and Safety of Baclofen for Maintenance of Abstinence in Alcohol Dependent Patients -Full Text View -ClinicalTrials.gov. http://clinicaltrials.gov/show, p.1738282

M. Auffret, R. B. Deheul, and S. , Severe Tinnitus Induced by Off-Label Baclofen, Annals of Pharmacotherapy, vol.104, issue.5, pp.656-665, 2014.
DOI : 10.3389/fneur.2012.00034

L. Rigal, L. Hoang, L. Alexandre-dubroeucq, C. Pinot, J. et al., Tolerability of High-dose Baclofen in the Treatment of Patients with Alcohol Disorders: A Retrospective Study, Alcohol and Alcoholism, vol.50, issue.5, pp.551-558, 2015.
DOI : 10.1093/alcalc/agv052

B. Rolland, J. Labreuche, and A. Duhamel, Baclofen for alcohol dependence: Relationships between baclofen and alcohol dosing and the occurrence of major sedation, European Neuropsychopharmacology, vol.25, issue.10, 2015.
DOI : 10.1016/j.euroneuro.2015.05.008

B. Rolland, S. Deheul, T. Danel, R. Bordet, and O. Cottencin, A Case of De novo Seizures Following a Probable Interaction of High-Dose Baclofen with Alcohol, Alcohol and Alcoholism, vol.47, issue.5, pp.577-80, 2012.
DOI : 10.1093/alcalc/ags076

P. Geoffroy, M. Auffret, S. Deheul, R. Bordet, O. Cottencin et al., Baclofen-Induced Manic Symptoms: Case Report and Systematic Review, Psychosomatics, vol.55, issue.4, pp.326-358, 2014.
DOI : 10.1016/j.psym.2014.02.003

B. Rolland, E. Jaillette, and L. Carton, Assessing Alcohol Versus Baclofen Withdrawal Syndrome in Patients Treated With Baclofen for Alcohol Use Disorder, Journal of Clinical Psychopharmacology, vol.34, issue.1, pp.153-159, 2014.
DOI : 10.1097/JCP.0000000000000054

A. Française-du-médicament-et-des-produits-de-santé, Recommandation temporaire d'utilisation (RTU) pour le baclofène -Point d'information 2014. http://ansm.sante.fr/Sinformer/Actualite/Une-recommandation-temporaire-d-utilisation-RTU-est-accordee-pour-lebaclofene-Point-d-information

J. Rehm, T. Greenfield, and J. Rogers, Average Volume of Alcohol Consumption, Patterns of Drinking, and All-Cause Mortality: Results from the US National Alcohol Survey, American Journal of Epidemiology, vol.153, issue.1, pp.64-71, 2001.
DOI : 10.1093/aje/153.1.64

J. Rehm and M. Roerecke, Reduction of Drinking in Problem Drinkers and All-Cause Mortality, Alcohol and Alcoholism, vol.48, issue.4, pp.509-522, 2013.
DOI : 10.1093/alcalc/agt021

S. Michie, C. Whittington, Z. Hamoudi, F. Zarnani, G. Tober et al., Identification of behaviour change techniques to reduce excessive alcohol consumption, Addiction, vol.103, issue.2, pp.1431-1471, 2012.
DOI : 10.1111/j.1360-0443.2012.03845.x

K. Mann, A. Bladström, L. Torup, A. Gual, and W. Van-den-brink, Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene, Biological Psychiatry, vol.73, issue.8, pp.706-719, 2013.
DOI : 10.1016/j.biopsych.2012.10.020

S. Rösner, S. Leucht, P. Lehert, and M. Soyka, Acamprosate supports abstinence, Naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes, Journal of Psychopharmacology, vol.22, issue.1, pp.11-23, 2008.
DOI : 10.1177/0269881107078308

P. Mcelhatton, The effects of benzodiazepine use during pregnancy and lactation, Reproductive Toxicology, vol.8, issue.6, pp.461-75, 1994.
DOI : 10.1016/0890-6238(94)90029-9

B. Wikner, C. Stiller, U. Bergman, C. Asker, and B. Källén, Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations, Pharmacoepidemiology and Drug Safety, vol.9, issue.11, pp.1203-1213, 2007.
DOI : 10.1002/pds.1457

S. Kuperman, G. Chan, and J. Kramer, Relationship of Age of First Drink to Child Behavioral Problems and Family Psychopathology, Alcoholism: Clinical & Experimental Research, vol.1, issue.10, pp.1869-76, 2005.
DOI : 10.1016/S0741-8329(99)00020-8

J. Grant, J. Scherrer, and M. Lynskey, Adolescent alcohol use is a risk factor for adult alcohol and drug dependence: evidence from a twin design, Psychological Medicine, vol.36, issue.01, pp.109-127, 2006.
DOI : 10.1017/S0033291705006045

C. Salzman, R. Shader, D. Greenblatt, and J. Harmatz, Long v short half-life benzodiazepines in the elderly???kinetics and clinical effects of diazepam and oxazepam, Journal of Clinical Psychopharmacology, vol.3, issue.4, pp.293-300, 1983.
DOI : 10.1097/00004714-198308000-00016

G. Wilkinson, The effects of liver disease and aging on the disposition of diazepam, chlordiazepoxide, oxazepam and lorazepam in man, Acta Psychiatrica Scandinavica, vol.25, issue.This suppl., pp.56-74, 1978.
DOI : 10.1111/j.1600-0447.1978.tb02388.x

A. Ballokova, N. Peel, D. Fialova, I. Scott, L. Gray et al., Use of benzodiazepines and association with falls in older people admitted to hospital: a prospective cohort study The epidemiology of at-risk and binge drinking among middle-aged and elderly community adults: National Survey on Drug Use and Health, 299?310. 67. Blazer DG, pp.1162-1171, 2009.

G. Addolorato, L. Leggio, and A. Ferrulli, Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study, The Lancet, vol.370, issue.9603, pp.1915-1937, 2007.
DOI : 10.1016/S0140-6736(07)61814-5

A. Dimartini, M. Dew, and N. Day, Trajectories of Alcohol Consumption Following Liver Transplantation, American Journal of Transplantation, vol.6, issue.10, pp.2305-2317, 2010.
DOI : 10.1111/j.1600-6143.2010.03232.x

M. Lucey, Liver transplantation in patients with alcoholic liver disease, Liver Transplantation, vol.42, issue.suppl), pp.751-760, 2011.
DOI : 10.1002/lt.22330

J. Dumortier, S. Dharancy, and A. Cannesson, Recurrent Alcoholic Cirrhosis In Severe Alcoholic Relapse After Liver Transplantation: A Frequent and Serious Complication, The American Journal of Gastroenterology, vol.105, issue.8, pp.1160-1166, 2015.
DOI : 10.1038/ajg.2015.204

E. Sullivan, M. Rosenbloom, K. Lim, and A. Pfefferbaum, Longitudinal changes in cognition, gait, and balance in abstinent and relapsed alcoholic men: Relationships to changes in brain structure., Neuropsychology, vol.14, issue.2, pp.178-88, 2000.
DOI : 10.1037/0894-4105.14.2.178

K. Davidson, Diagnosis of depression in alcohol dependence: changes in prevalence with drinking status, The British Journal of Psychiatry, vol.166, issue.2, pp.199-204, 1995.
DOI : 10.1192/bjp.166.2.199

J. Liappas, T. Paparrigopoulos, E. Tzavellas, and G. Christodoulou, Impact of alcohol detoxification on anxiety and depressive symptoms, Drug and Alcohol Dependence, vol.68, issue.2, pp.215-235, 2002.
DOI : 10.1016/S0376-8716(02)00195-3

M. Torrens, F. Fonseca, G. Mateu, M. Farré, M. Willenbring et al., Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment):681?91. 77. National Institute for Health and Clinical Excellence. Alcohol use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence, ):1?22. 76. Joseph AM, p.9, 2004.

A. Governement, Department of Health and Ageing. Guidelines for the Treatment of Alcohol Problems, 2009.

M. Peppers, Benzodiazepines for alcohol withdrawal in the elderly and in patients with liver disease, Pharmacotherapy, vol.16, pp.49-57, 1996.

M. Mayo-smith, Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal, JAMA: The Journal of the American Medical Association, vol.278, issue.2, pp.144-151, 1997.
DOI : 10.1001/jama.278.2.144

D. Greenblatt, Clinical Pharmacokinetics of Oxazepam and Lorazepam, Clinical Pharmacokinetics, vol.6, issue.2, pp.89-105, 1981.
DOI : 10.2165/00003088-198106020-00001

M. Leone, F. Vigna-taglianti, G. Avanzi, R. Brambilla, and F. Faggiano, Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses, Cochrane Database Syst Rev, vol.10, issue.1, p.6266, 2010.
DOI : 10.1002/14651858.CD006266.pub2

O. Ameisen, COMPLETE AND PROLONGED SUPPRESSION OF SYMPTOMS AND CONSEQUENCES OF ALCOHOL-DEPENDENCE USING HIGH-DOSE BACLOFEN: A SELF-CASE REPORT OF A PHYSICIAN, Alcohol and Alcoholism, vol.40, issue.2, pp.147-50, 2005.
DOI : 10.1093/alcalc/agh130

P. Gache, Baclofen: the new miracle cure for alcoholism?] Le baclofène sera-t-il le nouveau médicament miracle de l'alcoolisme?, Rev Med Suisse, vol.7, issue.302, pp.1458-61, 2011.

G. Dom, D. Jones, J. Currie, A. Mirijello, F. Caputo et al., Why Belgian alcohol patients are treated differently than their French counterparts High-dose baclofen for treatment-resistant alcohol dependence GABAB agonists for the treatment of Alcohol Use Disorder, 315?6. 86. Pastor A, pp.3367-72, 2012.

N. Heather, S. Adamson, D. Raistrick, and G. Slegg, Initial Preference for Drinking Goal in the Treatment of Alcohol Problems: I. Baseline Differences Between Abstinence and Non-Abstinence Groups, Alcohol and Alcoholism, vol.45, issue.2, pp.128-163, 2010.
DOI : 10.1093/alcalc/agp096

A. Gual, Y. He, L. Torup, W. Van-den-brink, K. Mann et al., ESENSE 2 Study Group. A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomized controlled 6-month studies, Eur Neuropsychopharmacol Alcohol Alcohol, vol.23, issue.485, pp.570-578, 2013.

H. Aubin, J. Reimer, and D. Nutt, Clinical Relevance of As-Needed Treatment with Nalmefene in Alcohol-Dependent Patients, European Addiction Research, vol.21, issue.3, pp.160-168, 2015.
DOI : 10.1159/000371547

C. François, N. Rahhali, Y. Chalem, P. Sørensen, A. Luquiens et al., The Effects of as-Needed Nalmefene on Patient-Reported Outcomes and Quality of Life in Relation to a Reduction in Alcohol Consumption in Alcohol-Dependent Patients, PLOS ONE, vol.10, issue.15, p.129289, 2015.
DOI : 10.1371/journal.pone.0129289.t004

K. Mann, Why should we need a European Federation of Addiction Societies?, Addiction, vol.88, issue.4, pp.6-8, 2008.
DOI : 10.1111/j.1360-0443.2011.03666.x